Ondine Biomedical's Steriwave antimicrobial treatment reduced surgical-site infections by 51.5% at the University of Ottawa Heart Institute, Canada's largest cardiac center, dropping infection rates from 3.3% to 1.6% in 2,172 procedures. Patient compliance improved significantly to 93.3% compared to 35.4% with the previous antibiotic regimen, as Steriwave is nurse-administered at point of care, replacing a multi-day self-treatment. These results support Steriwave's broader adoption in surgical pathways and build on positive Phase 3 trial data showing a 40.5% infection reduction across North America. Steriwave is authorized in Canada but remains investigational in the U.S.
Ondine Biomedical's Steriwave antimicrobial treatment is the story's subject, presented here with Pluang's health sector market context. As of Oct 23, 2026 14:31 WIB, 63 of 150 priced health-sector US stocks rose while 85 fell. Notable movers include HRTX at USD 0.29 with a -14.20% change and a 65% buy order activity, NUWE at USD 0.53 with a +7.63% change and 100% buy order activity, and MRVI at USD 7.05 with a -6.80% change and 100% buy order activity.
Ipsos posted €636.2 million revenue in Q3 2026 with 2.0% organic growth, up from 0.8% in H1, led by strong performances in EMEA, China, and its Citizens business. The company updated its full-year organic growth outlook to 1.2%-1.5%, citing ongoing g...
Ipsos achieved 2.0% organic revenue growth in Q3 2026, up from 0.8% in H1, driven by strong performances in EMEA, China, and citizen-related activities. The company updated its 2026 organic growth target to 1.2%-1.5%, reflecting improved momentum and...
Signify reported third-quarter 2026 results with sales of EUR 1,367 million, a slight decline in comparable sales by 3.4%, but improved adjusted EBITA of EUR 145 million and a margin increase to 10.6%. Net income rose to EUR 88 million and free cash ...
A single cryptocurrency wallet sold 246.25 BTC worth $20.64 million and purchased 8,286 ETH of equal value, indicating a rotation from Bitcoin to Ether rather than new capital entering the market. Over 11 days, the wallet sold 1,917.7 BTC for $159 mi...
Bitcoin's price fell nearly 1% to $81,449 on October 23 after failing to hold above $84,000, pressured by $635 million in net outflows from U.S. spot Bitcoin ETFs and $406 million in crypto liquidations affecting nearly 90,000 traders. Technical indi...
